FindTrial
Sign In

Anaesthetic efficacy of Inferior Alveolar Nerve Block in Diabetic patients with Symptomatic Irreversible Pulpitis

Evaluation of success rate of Inferior Alveolar Nerve Block in patients with type-2 Diabetes Mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036813
Enrollment
60
Registered
2021-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: diabetics: to evaluate the success rate of Iinferior alveolar nerve block in mandibular molars with Symptomatic Irreversible Pulpitis Control Intervention1: non diabetics: to evaluate

Sponsors

JCD Dental College Sirsa Haryana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients diagnosed with DM patients diagnosed with SIP patients >18 years of age patients giving informed consent

Exclusion criteria

Exclusion criteria: patients with patients with peri apical pathosis pregnant and lactating mothers

Design outcomes

Primary

MeasureTime frame
efficacy of IANB in type-2 DMTimepoint: base line, 15 minutes—

Secondary

MeasureTime frame
compare the efficacy of IANB in SIP in healthy and diabetic patientsTimepoint: base line, 15 minutes, 90 minutes.—

Countries

India

Contacts

Public ContactMani Gera

JCD Dental College Sirsa

singlaendo@gmail.com9729017534

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026